- Home
- AUTL vs EU Comparison
AUTL vs EU Comparison
Compare AUTL & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- EU
- Stock Information
- Founded
- AUTL 2014
- EU 2009
- Country
- AUTL United Kingdom
- EU United States
- Employees
- AUTL N/A
- EU N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- EU Other Metals and Minerals
- Sector
- AUTL Health Care
- EU Basic Materials
- Exchange
- AUTL Nasdaq
- EU Nasdaq
- Market Cap
- AUTL 625.4M
- EU N/A
- IPO Year
- AUTL 2018
- EU N/A
- Fundamental
- Price
- AUTL $2.25
- EU $2.86
- Analyst Decision
- AUTL Strong Buy
- EU Strong Buy
- Analyst Count
- AUTL 5
- EU 1
- Target Price
- AUTL $9.32
- EU $2.75
- AVG Volume (30 Days)
- AUTL 2.5M
- EU 3.6M
- Earning Date
- AUTL 08-07-2025
- EU 08-13-2025
- Dividend Yield
- AUTL N/A
- EU N/A
- EPS Growth
- AUTL N/A
- EU N/A
- EPS
- AUTL N/A
- EU N/A
- Revenue
- AUTL $9,011,000.00
- EU $46,179,000.00
- Revenue This Year
- AUTL $461.76
- EU $27.46
- Revenue Next Year
- AUTL $112.66
- EU $140.12
- P/E Ratio
- AUTL N/A
- EU N/A
- Revenue Growth
- AUTL N/A
- EU N/A
- 52 Week Low
- AUTL $1.11
- EU $1.01
- 52 Week High
- AUTL $5.00
- EU $4.44
- Technical
- Relative Strength Index (RSI)
- AUTL 69.32
- EU 73.07
- Support Level
- AUTL $1.98
- EU $2.25
- Resistance Level
- AUTL $2.10
- EU $2.61
- Average True Range (ATR)
- AUTL 0.13
- EU 0.19
- MACD
- AUTL -0.00
- EU 0.04
- Stochastic Oscillator
- AUTL 73.63
- EU 92.31
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.